174 related articles for article (PubMed ID: 9592312)
1. [A study on the loss of heterozygosity at the APC/MCC and DCC genetic loci in colorectal cancers].
Lui Y; Fang D; Lu R
Zhonghua Nei Ke Za Zhi; 1996 Jul; 35(7):439-43. PubMed ID: 9592312
[TBL] [Abstract][Full Text] [Related]
2. [The possible role of loss of heterozygosity at APC, MCC and DCC genetic loci in esophageal carcinoma].
Wang M; Lu R; Fang D
Zhonghua Zhong Liu Za Zhi; 1999 Jan; 21(1):16-8. PubMed ID: 11776787
[TBL] [Abstract][Full Text] [Related]
3. Study of loss of heterozygosity at DCC and APC/MCC genetic loci of gastric cancer.
Wang D; Fang D; Luo Y; Lu R; Liu W
Chin Med Sci J; 1999 Jun; 14(2):107-11. PubMed ID: 12901620
[TBL] [Abstract][Full Text] [Related]
4. APC gene loss of heterozygosity, mutations, E1317Q, and I1307K germ-line variants in sporadic colon cancer in Croatia.
Kapitanović S; Cacev T; Radosević S; Spaventi S; Spaventi R; Pavelić K
Exp Mol Pathol; 2004 Dec; 77(3):193-200. PubMed ID: 15507235
[TBL] [Abstract][Full Text] [Related]
5. [A study on the changes of DCC and MCC genes in colorectal carcinoma and adenoma].
Zhou Y; Zhou D; Yuan A
Zhonghua Nei Ke Za Zhi; 1996 Jul; 35(7):444-6. PubMed ID: 9592313
[TBL] [Abstract][Full Text] [Related]
6. [Loss of heterozygosity involving DCC gene in human colorectal cancers is correlated with the metastatic potential].
Gao S; Xu W; Wan Y
Zhonghua Zhong Liu Za Zhi; 1996 Jul; 18(4):250-2. PubMed ID: 9387312
[TBL] [Abstract][Full Text] [Related]
7. Involvement of the multiple tumor suppressor genes and 12-lipoxygenase in human prostate cancer. Therapeutic implications.
Gao X; Porter AT; Honn KV
Adv Exp Med Biol; 1997; 407():41-53. PubMed ID: 9321930
[TBL] [Abstract][Full Text] [Related]
8. Loss of heterozygosity of the Mutated in Colorectal Cancer gene is not associated with promoter methylation in non-small cell lung cancer.
Poursoltan P; Currey N; Pangon L; van Kralingen C; Selinger CI; Mahar A; Cooper WA; Kennedy CW; McCaughan BC; Trent R; Kohonen-Corish MR
Lung Cancer; 2012 Aug; 77(2):272-6. PubMed ID: 22542170
[TBL] [Abstract][Full Text] [Related]
9. [Study on loss of heterozygosity and microsatellite instability in hepatocellular carcinoma].
Cong WM; Zhang SH; Xian ZH; Wu WQ; Wu MC
Zhonghua Bing Li Xue Za Zhi; 2005 Feb; 34(2):71-4. PubMed ID: 15842799
[TBL] [Abstract][Full Text] [Related]
10. Concordance of genetic alterations in poorly differentiated colorectal neuroendocrine carcinomas and associated adenocarcinomas.
Vortmeyer AO; Lubensky IA; Merino MJ; Wang CY; Pham T; Furth EE; Zhuang Z
J Natl Cancer Inst; 1997 Oct; 89(19):1448-53. PubMed ID: 9326914
[TBL] [Abstract][Full Text] [Related]
11. Loss of heterozygosity of multiple tumor suppressor genes in human gastric cancers by polymerase chain reaction.
Cho JH; Noguchi M; Ochiai A; Hirohashi S
Lab Invest; 1996 Apr; 74(4):835-41. PubMed ID: 8606493
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of genetic mutations of tumor suppresser genes in colorectal cancer patients.
Kubo H; Miki C; Kusunoki M
Hepatogastroenterology; 2004; 51(55):114-7. PubMed ID: 15011843
[TBL] [Abstract][Full Text] [Related]
13. Genomic instability and alterations in Apc, Mcc and Dcc in Hong Kong patients with colorectal carcinoma.
Ko JM; Cheung MH; Kwan MW; Wong CM; Lau KW; Tang CM; Lung ML
Int J Cancer; 1999 Aug; 84(4):404-9. PubMed ID: 10404094
[TBL] [Abstract][Full Text] [Related]
14. Tumor progression and loss of heterozygosity at 5q and 18q in non-small cell lung cancer.
Fong KM; Zimmerman PV; Smith PJ
Cancer Res; 1995 Jan; 55(2):220-3. PubMed ID: 7812947
[TBL] [Abstract][Full Text] [Related]
15. DCC and SMAD4 alterations in human colorectal and pancreatic tumor dissemination.
Tarafa G; Villanueva A; Farré L; Rodríguez J; Musulén E; Reyes G; Seminago R; Olmedo E; Paules AB; Peinado MA; Bachs O; Capellá G
Oncogene; 2000 Jan; 19(4):546-55. PubMed ID: 10698524
[TBL] [Abstract][Full Text] [Related]
16. Somatic allelic loss at the DCC, APC, nm23-H1 and p53 tumor suppressor gene loci in human prostatic carcinoma.
Brewster SF; Browne S; Brown KW
J Urol; 1994 Apr; 151(4):1073-7. PubMed ID: 7510345
[TBL] [Abstract][Full Text] [Related]
17. Loss of heterozygosity at the p53, RB, DCC and APC tumor suppressor gene loci in human bladder cancer.
Miyamoto H; Shuin T; Ikeda I; Hosaka M; Kubota Y
J Urol; 1996 Apr; 155(4):1444-7. PubMed ID: 8632608
[TBL] [Abstract][Full Text] [Related]
18. [Relation between loss of heterozygosity at APC and MCC genetic loci and biological behaviour of gastric carcinoma].
Liu B; Zhang X; Yu W
Zhonghua Zhong Liu Za Zhi; 1996 Jan; 18(1):3-5. PubMed ID: 8732100
[TBL] [Abstract][Full Text] [Related]
19. Loss of heterozygosity affecting the p53, Rb, and mcc/apc tumor suppressor gene loci in dysplastic and cancerous ulcerative colitis.
Greenwald BD; Harpaz N; Yin J; Huang Y; Tong Y; Brown VL; McDaniel T; Newkirk C; Resau JH; Meltzer SJ
Cancer Res; 1992 Feb; 52(3):741-5. PubMed ID: 1346256
[TBL] [Abstract][Full Text] [Related]
20. Loss of heterozygosity affecting the APC and MCC genetic loci in patients with primary breast carcinomas.
Medeiros AC; Nagai MA; Neto MM; Brentani RR
Cancer Epidemiol Biomarkers Prev; 1994 Jun; 3(4):331-3. PubMed ID: 8061582
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]